| Dr Nathaniel James Buffington, MD | |
|
1001 Noble St, Fairbanks, AK 99701-4948 | |
| (907) 459-3500 | |
| (907) 459-3588 |
| Full Name | Dr Nathaniel James Buffington |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 1001 Noble St, Fairbanks, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316028947 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairbanks Memorial Hospital | Fairbanks, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tanana Valley Clinic Llc | 5698056901 | 105 |
News Archive
Antioxidant supplements do not improve semen quality among men with infertility, according to a new study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After a person receives acute care in a "regular" hospital for catastrophic illness, traumatic injury or a debilitating chronic condition, the next step in the process of recovery often involves a stay at an inpatient rehabilitation, or rehab, facility.Patients often have little warning when they're quickly moved to a rehab facility from acute care. Those who envision a long, leisurely recovery in a hospital or at home may find that the abrupt transition-and new responsibilities in rehab-leaves their heads spinning.
According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study.
› Verified 4 days ago
| Entity Name | Tanana Valley Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922559558 PECOS PAC ID: 5698056901 Enrollment ID: O20161228001991 |
News Archive
Antioxidant supplements do not improve semen quality among men with infertility, according to a new study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After a person receives acute care in a "regular" hospital for catastrophic illness, traumatic injury or a debilitating chronic condition, the next step in the process of recovery often involves a stay at an inpatient rehabilitation, or rehab, facility.Patients often have little warning when they're quickly moved to a rehab facility from acute care. Those who envision a long, leisurely recovery in a hospital or at home may find that the abrupt transition-and new responsibilities in rehab-leaves their heads spinning.
According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nathaniel James Buffington, MD 1001 Noble St Ste 1, Fairbanks, AK 99701-4991 Ph: (907) 459-3500 | Dr Nathaniel James Buffington, MD 1001 Noble St, Fairbanks, AK 99701-4948 Ph: (907) 459-3500 |
News Archive
Antioxidant supplements do not improve semen quality among men with infertility, according to a new study supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.
Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.
Adocia, a biotechnology company specialized in the development of ‘best-in-class' medicines from already approved therapeutic proteins, in particular proteins and oncologic treatments, launches today a phase IIa clinical trial on its ultra-fast acting formulation of insulin Lispro (Humalog, Eli Lilly) using its proprietary technology BioChaperone).
After a person receives acute care in a "regular" hospital for catastrophic illness, traumatic injury or a debilitating chronic condition, the next step in the process of recovery often involves a stay at an inpatient rehabilitation, or rehab, facility.Patients often have little warning when they're quickly moved to a rehab facility from acute care. Those who envision a long, leisurely recovery in a hospital or at home may find that the abrupt transition-and new responsibilities in rehab-leaves their heads spinning.
According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study.
› Verified 4 days ago
Dr. Mark Andrew Clifford, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 122 1st Ave, Suite 600, Fairbanks, AK 99701 Phone: 907-750-4124 Fax: 808-433-1558 | |
Abigail J Klager, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 W Cowles St, Fairbanks, AK 99701 Phone: 907-451-6682 | |
Angela Lucien, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1717 W Cowles St, Fairbanks, AK 99701 Phone: 907-452-8251 | |
Dr. Melinda F Evans, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1606 23rd Ave, Fairbanks, AK 99701 Phone: 907-455-4567 Fax: 907-458-1581 | |
Dr. Natalie Seibert Mayer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1867 Airport Way, Suite 120b, Fairbanks, AK 99701 Phone: 907-457-5050 Fax: 907-457-5034 | |
Dr. Peter John Dillon Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 Noble St, Fairbanks, AK 99701 Phone: 907-459-3500 Fax: 907-458-2628 | |
Dr. Russell Scott Pierce, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 751 Old Richardson Hwy Ste 200, Fairbanks, AK 99701 Phone: 907-457-9420 Fax: 907-457-1098 |